Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2022 Filed Nov 2, 2022 22:42 UTC |
LYONS GARY ADirector
|
SaleCommon Stock | 15,000 | $114.76 | $1,721,403.00 |
DisclosureSEC source: 0001209191-22-055393 · doc4.xml · nonDerivative · entry 2 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,697 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $113.21 to $115.40. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · ownership.direct: The reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:42 UTC |
LYONS GARY ADirector
|
Exercise / conversionCommon Stock | 15,000 | $12.71 | $190,650.00 |
DisclosureSEC source: 0001209191-22-055393 · doc4.xml · nonDerivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 22:28 UTC |
Boyer David W.Chief Corp. Affairs Officer
|
SaleCommon Stock | 1,295 | $114.12 | $147,785.40 |
DisclosureSEC source: 0001209191-22-055389 · doc4.xml · nonDerivative · entry 1 Boyer David W. · CIK 0001909817 · Chief Corp. Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,919 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 4,923 | $43.24 Strike: $43.24 | $212,870.52 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · derivative · entry 6 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,206 Underlying: Common Stock · 4,923 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted February 06, 2017 and vested monthly over four years. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 4,923 | $115.04 | $566,331.58 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · nonDerivative · entry 4 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,234 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 4,923 | $43.24 | $212,870.52 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · nonDerivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 5,077 | $43.24 Strike: $43.24 | $219,529.48 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · derivative · entry 5 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,129 Underlying: Common Stock · 5,077 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted February 06, 2017 and vested monthly over four years. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 5,077 | $115.02 | $583,965.68 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,234 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.09. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 21:45 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 5,077 | $43.24 | $219,529.48 |
DisclosureSEC source: 0001209191-22-054840 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 21:55 UTC |
BENEVICH ERICChief Commercial Officer
|
SaleCommon Stock | 4,960 | $110.82 | $549,681.58 |
DisclosureSEC source: 0001209191-22-054117 · doc4.xml · nonDerivative · entry 1 BENEVICH ERIC · CIK 0001643653 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,643 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $109.54 to $111.46. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: Includes an aggregate of 265 shares purchased on February 28, 2022 and August 31, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 23:00 UTC |
LYONS GARY ADirector
|
SaleCommon Stock | 5,000 | $110.54 | $552,711.00 |
DisclosureSEC source: 0001209191-22-052894 · doc4.xml · nonDerivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,697 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.00 to $111.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · ownership.direct: The reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:33 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 10,000 | $43.24 Strike: $43.24 | $432,400.00 |
DisclosureSEC source: 0001209191-22-052885 · doc4.xml · derivative · entry 3 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,206 Underlying: Common Stock · 10,000 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted February 06, 2017 and vested monthly over four years. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:33 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 10,000 | $111.04 | $1,110,446.00 |
DisclosureSEC source: 0001209191-22-052885 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,234 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.00 to $111.99. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:33 UTC |
Lippoldt DarinChief Legal Officer
|
Exercise / conversionCommon Stock | 10,000 | $43.24 | $432,400.00 |
DisclosureSEC source: 0001209191-22-052885 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 23:07 UTC |
Boyer David W.Chief Corp. Affairs Officer
|
SaleCommon Stock | 1,437 | $106.59 | $153,169.83 |
DisclosureSEC source: 0001209191-22-052896 · doc4.xml · nonDerivative · entry 1 Boyer David W. · CIK 0001909817 · Chief Corp. Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,214 F1 · kind: Sale of 1,437 shares of common stock issued upon vesting of 2,732 restricted stock units on October 3, 2022 to cover payroll and withholding taxes, with the balance of the shares (1,295) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:40 UTC |
Lippoldt DarinChief Legal Officer
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049330 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,234 Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 20:40 UTC |
Lippoldt DarinChief Legal Officer
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049330 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,334 F1 · balance_after: Includes an aggregate of 38 shares purchased on August 31, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 1,227 | $81.49 Strike: $81.49 | $99,988.23 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · derivative · entry 9 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,227 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option granted February 05, 2018 and vested monthly over four years Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 3,361 | $43.24 Strike: $43.24 | $145,329.64 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · derivative · entry 8 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,361 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option granted February 06, 2017 and vested monthly over four years Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionIncentive Stock Option · Derivative | 3,455 | $35.99 Strike: $35.99 | $124,345.45 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · derivative · entry 7 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,455 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted February 05, 2016 and vested monthly over four years. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionCommon Stock | 1,227 | $81.49 | $99,988.23 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · nonDerivative · entry 5 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionCommon Stock | 3,361 | $43.24 | $145,329.64 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · nonDerivative · entry 4 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionCommon Stock | 3,455 | $35.99 | $124,345.45 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · nonDerivative · entry 3 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 21,533 | $35.99 Strike: $35.99 | $774,972.67 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · derivative · entry 6 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,533 shares Expires 2026-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted February 05, 2016 and vested monthly over four years. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
SaleCommon Stock | 21,533 | $105.95 | $2,281,330.91 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · nonDerivative · entry 2 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,888 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.28 to $106.89. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: Includes an aggregate of 157 shares purchased on February 28, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 22:44 UTC |
Lloyd-Smith MalcolmChief Regulatory Officer
|
Exercise / conversionCommon Stock | 21,533 | $35.99 | $774,972.67 |
DisclosureSEC source: 0001209191-22-046070 · doc4.xml · nonDerivative · entry 1 Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 22:54 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 1,816 | $100.00 | $181,600.00 |
DisclosureSEC source: 0001209191-22-045082 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,102 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 20:26 UTC |
Cooke JulieChief Human Resources Officer
|
SaleCommon Stock | 754 | $100.00 | $75,400.00 |
DisclosureSEC source: 0001209191-22-039808 · doc4.xml · nonDerivative · entry 1 Cooke Julie · CIK 0001776977 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,918 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · balance_after: Includes an aggregate of 261 shares purchased on February 28, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:18 UTC |
SHERWIN STEPHEN ADirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-031003 · doc4.xml · derivative · entry 1 SHERWIN STEPHEN A · CIK 0001079462 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:16 UTC |
Sharp ShaliniDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030998 · doc4.xml · derivative · entry 1 Sharp Shalini · CIK 0001377202 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:14 UTC |
RASTETTER WILLIAM HDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030992 · doc4.xml · derivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:11 UTC |
POPS RICHARD FDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030984 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:09 UTC |
Norwalk Leslie VDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030979 · doc4.xml · derivative · entry 1 Norwalk Leslie V · CIK 0001533568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:04 UTC |
Mercier JohannaDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030960 · doc4.xml · derivative · entry 1 Mercier Johanna · CIK 0001782135 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:07 UTC |
MORROW GEORGE JDirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030971 · doc4.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:02 UTC |
LYONS GARY ADirector
|
GrantNon-Qualified Stock Option · Derivative | 9,724 | $0.00 Strike: $84.95 | $0.00 |
DisclosureSEC source: 0001209191-22-030951 · doc4.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,724 Underlying: Common Stock · 9,724 shares Expires 2032-05-18 F1 · derivative.exercise_date: Option vests in 12 monthly installments beginning June 18, 2022. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 7,500 | $6.66 Strike: $6.66 | $49,950.00 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · derivative · entry 6 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted May 23, 2012 and vested monthly over one year. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 7,500 | $6.66 Strike: $6.66 | $49,950.00 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted May 23, 2012 and vested monthly over one year. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
SaleCommon Stock | 7,500 | $76.30 | $572,251.50 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,512 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $75.57 to $78.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
Exercise / conversionCommon Stock | 7,500 | $6.66 | $49,950.00 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
SaleCommon Stock | 7,500 | $76.29 | $572,211.00 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,512 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $75.54 to $78.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:36 UTC |
POPS RICHARD FDirector
|
Exercise / conversionCommon Stock | 7,500 | $6.66 | $49,950.00 |
DisclosureSEC source: 0001209191-22-028369 · doc4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 21:26 UTC |
LYONS GARY ADirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 15,000 | $6.66 Strike: $6.66 | $99,900.00 |
DisclosureSEC source: 0001209191-22-025824 · doc4.xml · derivative · entry 3 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option granted May 23, 2012 and vested monthly over one year. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 21:26 UTC |
LYONS GARY ADirector
|
SaleCommon Stock | 15,000 | $92.76 | $1,391,392.50 |
DisclosureSEC source: 0001209191-22-025824 · doc4.xml · nonDerivative · entry 2 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,697 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $91.53 to $93.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · ownership.direct: The reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 21:26 UTC |
LYONS GARY ADirector
|
Exercise / conversionCommon Stock | 15,000 | $6.66 | $99,900.00 |
DisclosureSEC source: 0001209191-22-025824 · doc4.xml · nonDerivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:20 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionNon-Qualified Stock Option · Derivative | 20,000 | $6.66 Strike: $6.66 | $133,200.00 |
DisclosureSEC source: 0001209191-22-023284 · doc4.xml · derivative · entry 3 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted May 23, 2012 and vested in 12 equal monthly installments beginning June 23, 2012. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:20 UTC |
RASTETTER WILLIAM HDirector
|
SaleCommon Stock | 10,728 | $94.93 | $1,018,366.13 |
DisclosureSEC source: 0001209191-22-023284 · doc4.xml · nonDerivative · entry 2 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,022 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $93.48 to $95.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:20 UTC |
RASTETTER WILLIAM HDirector
|
Exercise / conversionCommon Stock | 20,000 | $6.66 | $133,200.00 |
DisclosureSEC source: 0001209191-22-023284 · doc4.xml · nonDerivative · entry 1 RASTETTER WILLIAM H · CIK 0001205903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2022 Filed Mar 22, 2022 22:55 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 8,455 | $95.05 | $803,656.21 |
DisclosureSEC source: 0001209191-22-020615 · doc4.xml · nonDerivative · entry 2 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,396 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.17. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: Includes an aggregate of 39 shares purchased on February 28, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 22:55 UTC |
Lippoldt DarinChief Legal Officer
|
SaleCommon Stock | 300 | $95.00 | $28,500.00 |
DisclosureSEC source: 0001209191-22-020615 · doc4.xml · nonDerivative · entry 1 Lippoldt Darin · CIK 0001504783 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,851 F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions consistent with Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.